Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
Open Access
- 12 May 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (10), 3935-3944
- https://doi.org/10.1158/0008-5472.can-09-4396
Abstract
The chemokine receptor CXCR4 and its cognate ligand CXCL12 are pivotal for establishing metastases from many tumor types. Thus, CXCR4 may offer a cell surface target for molecular imaging of metastases, assisting diagnosis, staging, and therapeutic monitoring. Furthermore, noninvasive detection of CXCR4 status of a primary tumor may provide an index of the metastatic potential of the lesion. Here, we report the development and evaluation of [64Cu]AMD3100, a positron-emitting analogue of the stem cell mobilizing agent plerixafor to image CXCR4 in human tumor xenografts preselected for graded expression of this receptor. This imaging method was evaluated in lung metastases derived from human MDA-MB-231 breast cancer cells. Ex vivo biodistribution studies, performed to validate the in vivo imaging data, confirmed the ability of [64Cu]AMD3100 to image CXCR4 expression. Our findings show the feasibility of imaging CXCR4 by positron emission tomography using a clinically approved agent as a molecular scaffold. Cancer Res; 70(10); 3935–44. ©2010 AACR.Keywords
Other Versions
This publication has 52 references indexed in Scilit:
- Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CTJournal of Nuclear Medicine, 2009
- Binding Optimization through Coordination Chemistry: CXCR4 Chemokine Receptor Antagonists from Ultrarigid Metal ComplexesJournal of the American Chemical Society, 2009
- 64Cu-AMD3100—A novel imaging agent for targeting chemokine receptor CXCR4Bioorganic & Medicinal Chemistry, 2009
- Hypoxia- and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1α/CXCR4 Expression in Glioblastomas: One Plausible Explanation of Scherer's StructuresThe American Journal of Pathology, 2008
- A Significant Correlation between Nuclear CXCR4 Expression and Axillary Lymph Node Metastasis in Hormonal Receptor Negative Breast CancerAnnals of Surgical Oncology, 2007
- Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancerAnnals of Oncology, 2006
- Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumorsNuclear Medicine and Biology, 2006
- CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood, 2006
- The role of CXCR4 receptor expression in breast cancer: a large tissue microarray studyBreast Cancer Research and Treatment, 2005
- Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasisThe FASEB Journal, 2004